Cite

HARVARD Citation

    Pérez-Martínez, A. et al. (2021). Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE). EClinicalMedicine. p. . [Online]. 
  
Back to record